Encara no tenim significats per a "survive patients".
1All surviving patients who remained in remission had stable marrow graft function.
2Echocardiographic follow-up showed no progression of the regurgitation in 58 surviving patients.
3All surviving patients have been followed for more than 4 years.
4Median follow-up of all surviving patients was 65 weeks after radiosurgery.
5All surviving patients apart from a single individual had an isolated, circumscribed recurrence.
6The mean age of the surviving patients was 5 years.
7Sixty-two percent of surviving patients were developmentally normal or had only mild learning problems.
8The median follow-up time in surviving patients was 30 months.
9In addition, all surviving patients received a follow-up echocardiographic examination.
10Impaired renal function was found postoperatively in 45% of the surviving patients.
11In survived patients, MPI at discharge showed higher predictive accuracy than MPI at admission.
12Catecholamine levels were high initially and decreased in surviving patients.
13One of the surviving patients had two marrow transplant procedures because of recurrent leukemia.
14The functional capacity of surviving patients was remarkably good, even when presented in cardiogenic shock.
15Worsening of symptom scores in surviving patients was consistently more common in the enalapril group.
16Median follow-up time for surviving patients exceeds 7 years.